73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Guideline updated for initial management of advanced prostate cancer

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri

Guideline updated for initial management of advanced prostate cancer

by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Scientists identify link between mitochondria and pancreatic cancer risk

Scientists identify link between mitochondria and pancreatic cancer risk

byThe Wistar InstituteDifferential expression of a Mic60-low gene signature in cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0273520The mitochondria is a key energy-produc

Scientists identify link between mitochondria and pancreatic cancer risk

byThe Wistar InstituteDifferential expression of a Mic60-low gene signature in cancer. Credit:PLOS ONE(2022). DOI: 10.1371/journal.pone.0273520The mitochondria is a key energy-produc
Longer wait for some forms of cancer diagnosis for Black and Asian patients

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v

Longer wait for some forms of cancer diagnosis for Black and Asian patients

byUniversity of ExeterSite-specific box and Whisker plots showing ethnic differences in the number of days to diagnosis (lower adjacent value, 25th, 50th, and 75th centiles, and upper adjacent v
Researchers uncover new vulnerability in kidney cancer

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i
Rituximab Maintenance Effective for Autoimmune Cytopenias

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w

Rituximab Maintenance Effective for Autoimmune Cytopenias

August 2023Thomas R. CollinsPatients with autoimmune cytopenias had longer durations of response after induction treatment with rituximab when rituximab was continued as maintenance therapy compared w
Machine learning-triggered reminders improve end-of-life care for patients with cancer

Machine learning-triggered reminders improve end-of-life care for patients with cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainElectronic nudges delivered to health care clinicians based on a machine learning algorithm that p

Machine learning-triggered reminders improve end-of-life care for patients with cancer

byPerelman School of Medicine at the University of PennsylvaniaCredit: Pixabay/CC0 Public DomainElectronic nudges delivered to health care clinicians based on a machine learning algorithm that p
Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc
Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification
Finding familiar pathways in kidney cancer

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w

Finding familiar pathways in kidney cancer

byThomas Jefferson UniversityCredit: CC0 Public Domainp53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene—w
Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM

Combining cholesterol-lowering statins with existing cancer drug shows potent effect against breast cancer subtype

by Katie Brace,Beth Israel Deaconess Medical CenterTN/ER-low PDOs are sensitive to combination AZD5363 and pitavastatin. A panel of breast cancer PDOs were treated with DMSO, 1 µM AZD5363, 5 µM
FDA approves new treatment for advanced melanoma

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th

FDA approves new treatment for advanced melanoma

by Robin FosterThe U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.Amtagvi, made by Iovance Biotherapeutics Inc., becomes th